B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PKN2

MOLECULAR TARGET

protein kinase N2

NCBI Gene: 558633 compounds

PKN2 (protein kinase N2) is targeted by 33 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PKN2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tofacitinib4.65104
2tozasertib4.3375
3bosutinib4.0858
4midostaurin3.8546
5fasudil3.6638
6nintedanib3.6136
7baricitinib3.5634
8y 276323.4731
9tae 6843.4330
10dovitinib3.0921
11jnj 77066213.0921
12at 92833.0921
13lestaurtinib3.0420
14ruboxistaurin2.9418
15r 4062.8316
16k 252a2.8316
17crenolanib2.7114
18kw 24492.6413
19gsk 6906932.6413
20zotiraciclib2.5612
21gsk 4613642.4010
22ripasudil2.4010
23hydroxyfasudil2.4010
24azd 77622.309
25su 0148132.208
26y 399832.208
27rg 5472.087
28hydroxyfasudil [Supplementary Concept]1.795
29ucn 011.795
30sar 407899 free base1.795
31alsterpaullone0.691
32Axitinib0.691
33Dasatinib0.691

About PKN2 as a Drug Target

PKN2 (protein kinase N2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 33 compounds with documented PKN2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PKN2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.